Evidence map›Paper›PMID 31230721›Full record

ArticleAmerican journal of human genetics2019

De Novo Variants in TAOK1 Cause Neurodevelopmental Disorders.

Marija Dulovic-Mahlow, Joanne Trinh, Krishna Kumar Kandaswamy, Geir Julius Braathen, Nataliya Di Donato, Elisa Rahikkala, Skadi Beblo, Martin Werber, Victor Krajka, Øyvind L Busk and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Expanding the phenotype and genotype spectrum of TAOK1 neurodevelopmental disorder and delineating TAOK2 neurodevelopmental disorder.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Inherited and de novo variants extend the etiology ofCold Spring Harbor molecular case studies · 2022
    Article
  14. Paternal De Novo Variant ofFrontiers in genetics · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The importance of genetic testing for dystonia patients and translational research.Journal of neural transmission (Vienna, Austria : 1996) · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 5 countries.

Marija Dulovic-MahlowInstitute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany.
Joanne TrinhInstitute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany.
Krishna Kumar KandaswamyCentogene AG, 18055 Rostock, Germany.
Geir Julius BraathenDepartment of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway.
Nataliya Di DonatoInstitute of Clinical Genetics, Technical University of Dresden, Dresden, Germany.
Elisa RahikkalaResearch Unit for Pediatrics, Pediatric Neurology, Pediatric Surgery, Child Psychiatry, Dermatology, Clinical Genetics, Obstetrics and Gynecology, Otorhinolaryngology and Ophthalmology (PEDEGO Research Unit) and Medical Research Center Oulu, University of Oulu and Oulu University Hospital, 90029 OYS Oulu, Finland; Department of Clinical Genetics, Oulu University Hospital, 90029 OYS Oulu, Finland.
Skadi BebloInstitute of Human Genetics, University Hospital Leipzig, 04103 Leipzig, Germany; Center for Pediatric Research Leipzig, Department of Women and Child Health, Hospital for Children and Adolescents, University Hospitals, 04103 Leipzig, Germany.
Martin WerberCentogene AG, 18055 Rostock, Germany.
Victor KrajkaInstitute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany.
Øyvind L BuskDepartment of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway.
Hauke BaumannInstitute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany.
Nouriya Abbas Al-SannaaDepartment of Pediatric Services, Johns Hopkins Aramco Health Care, 34465 Dharan, Saudi Arabia.
Frauke HinrichsInstitute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany.
Rabea AffanPronto Diagnostics, 6158002 Tel Aviv, Israel.
Nir NavotPronto Diagnostics, 6158002 Tel Aviv, Israel.
Mohammed A Al BalwiDepartment of Pathology and Laboratory Medicine, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, King Abdulaziz Medical City, 11426 Riyadh, Saudi Arabia.
Gabriela OpreaCentogene AG, 18055 Rostock, Germany.
Øystein L HollaDepartment of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway.
Maximilian E R WeissCentogene AG, 18055 Rostock, Germany.
Rami A JamraInstitute of Human Genetics, University Hospital Leipzig, 04103 Leipzig, Germany.
Anne-Karin KahlertInstitute of Clinical Genetics, Technical University of Dresden, Dresden, Germany.
Shivendra KishoreCentogene AG, 18055 Rostock, Germany.
Kristian TvetenDepartment of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway.
Melissa VosInstitute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany.
Arndt RolfsCentogene AG, 18055 Rostock, Germany; University of Rostock, 18147 Rostock, Germany.
Katja LohmannInstitute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany. Electronic address: katja.lohmann@neuro.uni-luebeck.de.
University of Lübeck · DECentogene (Germany) · DETelemark Hospital · NOPronto Diagnostics (Israel) · ILTU Dresden · DEUniversity Hospital Leipzig · DEKing Abdullah International Medical Research Center · SAOulu University Hospital · FISaudi Aramco Medical Services Organization · SAUniversity of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

De novo variants represent a significant cause of neurodevelopmental delay and intellectual disability. A genetic basis can be identified in only half of individuals who have neurodevelopmental disorders (NDDs); this indicates that additional causes need to be elucidated. We compared the frequency of de novo variants in patient-parent trios with (n = 2,030) versus without (n = 2,755) NDDs. We identified de novo variants in TAOK1 (thousand and one [TAO] amino acid kinase 1), which encodes the serine/threonine-protein kinase TAO1, in three individuals with NDDs but not in persons who did not have NDDs. Through further screening and the use of GeneMatcher, five additional individuals with NDDs were found to have de novo variants. All eight variants were absent from gnomAD (Genome Aggregation Database). The variant carriers shared a non-specific phenotype of developmental delay, and six individuals had additional muscular hypotonia. We established a fibroblast line of one mutation carrier, and we demonstrated that reduced mRNA levels of TAOK1 could be increased upon cycloheximide treatment. These results indicate nonsense-mediated mRNA decay. Further, there was neither detectable phosphorylated TAO1 kinase nor phosphorylated tau in these cells, and mitochondrial morphology was altered. Knockdown of the ortholog gene Tao1 (Tao, CG14217) in Drosophila resulted in delayed early development. The majority of the Tao1-knockdown flies did not survive beyond the third instar larval stage. When compared to control flies, Tao1 knockdown flies revealed changed morphology of the ventral nerve cord and the neuromuscular junctions as well as a decreased number of endings (boutons). Furthermore, mitochondria in mutant flies showed altered distribution and decreased size in axons of motor neurons. Thus, we provide compelling evidence that de novo variants in TAOK1 cause NDDs.

Indexed as

MutationAnimalsChildDrosophila melanogasterExomeExome SequencingFemaleHeterozygoteHumansMaleNeurodevelopmental DisordersPhenotypeProtein Serine-Threonine KinasesProtein Serine-Threonine KinasesTAO1 protein kinasede novo variantsfly modelneurodevelopmental disordersTAO kinase 1

Identifiers

PMID31230721
PMCPMC6612514
OpenAlexW2949840267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.